Healthcare - Biotechnology - NASDAQ - US
$ 3.22
-2.72 %
$ 272 M
Market Cap
-1.56
P/E
Price Target
Average
113.66%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
42.90%
Net Income
Estimate
28.52%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Atea Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for AVIR of $6.88 , with forecasts ranging from a low of $6.88 to a high of $6.88 .
AVIR Lowest Price Target
Wall Street Target
6.88 USD
113.66%
AVIR Average Price Target
Wall Street Target
6.88 USD
113.66%
AVIR Highest Price Target
Wall Street Target
6.88 USD
113.66%
REVENUE FORECAST
Revenue Forecast Chart AVIR
EBIT FORECAST
EBIT Forecast Chart AVIR
NET INCOME FORECAST
Net Income Chart AVIR